Moderna Testing Potential Monkeypox Vaccines in Pre-Clinical Trials

Moderna Testing Potential Monkeypox Vaccines in Pre-Clinical Trials
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder
|Updated:

Moderna Inc. said on Monday that it testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.

The announcement comes as the World Health Organization (WHO) said on Tuesday that there have been 131 cases of monkeypox identified around the world, with most of them occurring in Spain, Portugal, and the United Kingdom.
Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.
Related Topics